ID
23887
Descripción
Study part: General Medical History/ Physical Examination Visit 1. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381
Palabras clave
Versiones (1)
- 16/7/17 16/7/17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
16 de julio de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
General Medical History/ Physical Examination Visit 1 Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381
General Medical History/ Physical Examination Visit 1
- StudyEvent: ODM
Similar models
General Medical History/ Physical Examination Visit 1
- StudyEvent: ODM
C0221912 (UMLS CUI [1,2])
C0221912 (UMLS CUI [1,2])
C0015392 (UMLS CUI [1,2])
C0015392 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C3887460 (UMLS CUI [1,2])
C3887460 (UMLS CUI [1,2])
C0035237 (UMLS CUI [1,2])
C0035237 (UMLS CUI [1,2])
C0521362 (UMLS CUI [1,2])
C0521362 (UMLS CUI [1,2])
C0026860 (UMLS CUI [1,2])
C0026860 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
C0042066 (UMLS CUI [1,2])
C0042066 (UMLS CUI [1,2])
C0474523 (UMLS CUI [1,2])
C0474523 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])